AMA CPT® Assistant - 2023 Issue 8 (August)
New COVID-19 Vaccine Codes: August Update (August Special Update 2023)
August Special Update 2023 New COVID-19 Vaccine Codes: August Update Based on recent recommendations made by the Food and Drug Administration (FDA) to shift to a monovalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019 [COVID-19]) vaccine that targets the predominant XBB lineage virus strain for the 2023-2024 vaccine administration season, the Current Procedural Terminology (CPT®) Editorial Panel (the Panel) has approved new monovalent COVID-19 vaccine product codes for Pfizer and Moderna vaccines. Codes 91318, 91319, 91320 were approved for the new monovalent vaccine products from Pfizer, and codes 91321 and 91322 were approved for the...
Subscribe or sign in to view the full article.
Article Overview
This CPT Assistant special update covers the August 2023 changes to COVID-19 vaccine coding, including new product and administration codes, deleted codes, retained vaccine coding, and the planned removal of a CPT appendix. It is relevant for coding professionals, billing teams, and clinicians who report immunization services and need to stay aligned with current CPT guidance and external vaccine recommendations.
Why This Topic Matters
The article helps readers understand how recent vaccine recommendation changes affect CPT reporting and how the COVID-19 vaccine code structure is being revised for the 2023-2024 season. It is important for maintaining accurate, current immunization claims and for identifying which CPT references remain active versus those being retired.
Article Sections
-
August Special Update 2023
Introduces the update and frames the CPT COVID-19 vaccine changes discussed in the article. It provides general context for the guidance that follows.
-
Immunization Administration for Vaccines/Toxoids
Summarizes the administration coding section for COVID-19 vaccine reporting. The section focuses on the updated structure for immunization administration guidance.
-
Vaccines, Toxoids
Presents the vaccine product coding section and associated updates for COVID-19 vaccine products. It covers the revised product code structure and related reporting context.
-
Table 1. New Pfizer Vaccine Product Codes & Age Ranges
Lists the newly added Pfizer product code information and age ranges. It is part of the product-code update for the 2023-2024 season.
-
Table 2. New Moderna Vaccine Product Codes & Age Ranges
Lists the newly added Moderna product code information and age ranges. It is part of the product-code update for the 2023-2024 season.
-
Table 3. Deleted COVID-19 Vaccine Product & Vaccine Administration Codes
Identifies previously used COVID-19 vaccine product and administration codes scheduled for deletion. The table also organizes the information by manufacturer and age range.
-
Table 4: Retained COVID-19 Vaccine Product
Highlights the COVID-19 vaccine product code that remains active after the update. It also notes the surrounding context for reporting changes.
-
Typical Patient / Description of Procedure examples
Provides clinical examples and procedural narratives illustrating the updated COVID-19 vaccine coding context. The examples are presented for the listed product and administration codes.
What You Will Learn
- How the August 2023 CPT update changes COVID-19 vaccine coding
- Which general categories of vaccine codes were added, deleted, or retained
- How the update relates to FDA and CDC-aligned vaccine guidance
- How the revised administration structure is organized in CPT
- What types of clinical examples and procedural scenarios are included
Who Should Read This
- Medical coders
- Billing and reimbursement staff
- Health information management professionals
- Immunization clinic staff
- Physicians and other qualified health care professionals
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com
